Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
INF-904 by InflaRx for Chronic Inflammation: Likelihood of Approval
INF-904 is under clinical development by InflaRx and currently in Phase I for Chronic Inflammation. According to GlobalData, Phase I...
INF-904 by InflaRx for Autoimmune Disorders: Likelihood of Approval
INF-904 is under clinical development by InflaRx and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I...
INF-904 by InflaRx for Chronic Urticaria Or Hives: Likelihood of Approval
INF-904 is under clinical development by InflaRx and currently in Phase I for Chronic Urticaria Or Hives. According to GlobalData,...